PNB Vesper Life Sciences
-
PNB Vesper completes Phase 2 clinical trials of GPP-Baladol on COVID-19 patients
The clinical trial report will be submitted to Drug Controller General of India on February 22, 2021 Kerala-based PNB Vesper…
Read More »